Quantitative evaluation of apoptosis and proliferation in renal cell carcinoma. Correlation to tumor subtype, cytological grade according to thoenes-classification and the occurrence of metastasis

Pathology Research and Practice

Volumn 193, Issue 1, 1997, Pages 1-7

  Hindermann, Winfried ^a   Berndt, Alexander ^a   Wunderlich, Heiko ^a   Katenkamp, Detlef ^a   Kosmehl, Hartwig ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Apoptosis; Proliferation; Renal cell carcinoma; TUNEL method

Indexed keywords

KI 67 ANTIGEN;

APOPTOSIS; ARTICLE; CANCER GRADING; CELL DEATH; CELL PROLIFERATION; DNA STRAND BREAKAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; METASTASIS; ONCOCYTOMA; TUMOR GROWTH;

EID: 0030955255     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(97)80088-X     Document Type: Article

References (56)

1. Barettpm GB, Diebold J, Christoferis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U (1996) Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 77, 255-264
2. Bot FJ, Godschalk JC, Krishnadath KK, van der Kwast TH, Bosmann FT (1994) Prognostic factors in renal cell carcinoma: immunohistochemical detection of p53 protein versus clinico-pathological parameters. Int J Cancer 57, 634-637
3. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17, 489-503
4. Cattoretti G, Pileri S, Parravicini C, Backer MHG, Poggi S, Bifluco C, Key G, D'amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171, 83-98
5. Chemeris G, Loktinov A, Rempel A, Schwarz M, Bannasch P (1995) Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Virchows Arch 426, 563-569
6. Cordell JL, Falini B, Erber WN, Gosh AK, Abdulaizz, Z, McDonald S, Pulford K, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32, 219-229
7. Craig RW (1995) The bcl-2 gene family. Semin Cancer Biol 6, 35-43
8. Delahunt B, Bethwait PB, Thronton A, Ribas JL (1995) Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labelling. Cancer 75, 2714-2719
9. deRiese WT, Crabtree WN, Allhoff IP, Werner M, Liedke S, Lenis G, Atzpodien J, Kirchner H (1993) Prognostic significance of Ki-67 immunostaining in nonmetastatic renal carcinoma. J Clin Oncol 11, 1804-1808
10. deRiese W, Allhoff E, Werber M, Atzpodien J, Kirchner H, Stief CG (1991) Proliferating behaviour and cytogenetic changes in human renal cell carcinoma. World J Urol 9, 20-27
11. deRiese W, Haupt G, Senge T, Crabtree WN, deRiese C (1994) Ki-67 immunostaining as a new independent prognosticator in nonmetastatic renal cell carcinoma [abstract]. J Urol 151, 386A
12. Eastmann A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin Cancer Biol 6, 45-52
13. Gavrieli Y, Shermann Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119, 493-501
14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133, 1710-1715
15. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD (1991) Immunobiochemical and molecular biologic characterisation of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138, 867-873
16. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31, 13-20
17. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H (1994) Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71, 219-225
18. Grasel-Kraup B, Ruttaky-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R (1995) In situ detection of fragment DNA (TUNEL assay). Fails to discriminate among apoptosis, necrosis and autolytic cell death: a cautionary note. Hepatology 21, 1465-1468
19. Gustmann C, Altmannsberger M, Osborn M, Griesser H, Feller AC (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other Non-Hodgkin's Lymphomas. Am J Pathol 138, 1413-1425
20. Hall PA, Levison DA (1990) Review: assessment of cell proliferation in histological material. J Clin Pathol 43, 184-192
21. Henkart PA (1995) Apoptosis: O death, where is thy sting? J Immunol 154, 4905-4908
22. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ (1991) Bcl-2 protein is topographical restricted in tissues characterized by apoptotic cell death. Procl Natl Acad Sci USA 88, 6961-6965
23. Hockenbery DM (1995) Defining apoptosis. Am J Pathol 146, 16-19
24. Hofmockel G, Tsatalpas P, Müller H, Dämmrich J, Poot M, Maurer-Schulze B, Müller-Hermelink HK, Frohmüller HGW, Bassukas ID (1995) Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer 76, 296-306
25. Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, Takahashi A, Kuroiwa M (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30, 805-808
26. Kaiser U, Hansmann ML, Papadopoulos I (1991) Does the immunophenotype of renal cell carcinoma correlate with its clinical stage? Urol Int 47, 194-198
27. Kasagi N, Gomoyo Y, Shirai H, Tsujitani S, Ito H (1994) Apoptotic cell death in human gastric carcinoma: analysis by TUNEL. Jpn J Cancer Res 85, 939-945
28. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis - its significance in cancer and cancer therapy. Cancer 73, 2013-2026
29. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257
30. Kokunai T, Sawa H, Tamaki N (1995) Localization of apoptotic cells in situ of brain tumors. Brain Tumor Pathol 12, 15-21
31. Leoncini L, Del Vecchio MT, Megha T, Barbini P, Galieni P, Pileri S, Sabattini E, Gherlinzoni F, Tosi P, Kraft R, Cottier H (1993) Correlations between apoptotic and proliferative indices in malignant Non-Hodgkin's Lymphomas. Am J Pathol 142, 755-763
32. Lipponen P, Eskelinen M, Syrjanen K (1995) Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have not independent prognostic value in renal adenocarcinoma. Br J Cancer 71, 863-867
33. Liu TJ, El-Naggar AK, McDonnel TJ, Steck KD, Wang M, Taylor DL, Claymann GL (1995) Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 55, 3117-3122
34. Lorenzen J, Alavaikko M, Hansmann ML (1995) Apoptose beim Morbus Hodgkin. Pathologe 16, 208-216
35. Marushige K, Marushige Y (1994) Induction of apoptosis by transforming growth factor β1 in glioma and trigeminal cells. Anticancer Res 14, 2419-2424
36. McCall CA, Cohen JJ (1991) Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 97, 111-114
37. McCormick D, Chong H, Hobbs C, Datta C, Hall PA (1993) Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathol 22, 355-360
38. Mizutani Y, Bonavida B. Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O (1995) Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum (II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Cancer Res 55, 590-596
39. Money EE, Ruis-Peris JM, O'Neill A, Sweeney EC (1995) Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48, 242-244
40. Moreira LF, Naomoto, Y, Hamada M, Kamikawa Y, Orita K (1995) Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res 15, 639-644
41. Nakawaga S, Shiaishi T, Kihara S, Tabuchi K (1995) Detection of DNA strand breaks associated with apoptosis in human brain tumors. Virchows Arch 427, 175-179
42. Ohbu M, Saegusa M, Okayasu I (1995) Apoptosis and cell proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types. Virchows Arch 427, 271-276
43. Osborn BA (1995) Induction of genes during apoptosis: examples from the immune system. Cancer Biol 6, 27-33
44. Papadopolus I, Weichert-Jacobsen K, Sprenger E, Wacker HH (1994) DNA content and the proliferation marker Ki-67 as prognostic indicators in renal cell carcinoma. Urol Int 53, 181-185
45. Pitch A, Valente G, Azzoni L, Stramignoni A, Margaria E, Tasso M (1991) Argyrophilic nuclear organizer region counts and Ki-67 scores in human renal cell carcinoma. Path Res Pract 187, 482-486
46. Quirk SM, Cowan RG, Joshi SG, Henrikson KP (1995) Fas antigen-mediated apoptosis in human granulosa/ luteal cells. Biol Reprod 52, 279-287
47. Schulte-Hermann R, Grasl-Kraupp B, Bursch W (1994) Tumor development and apoptosis. Int Arch Allergy Immunol 105, 363-367
48. Seki H, Demura T, Nagamori S, Nonomura K, Koyanagi T (1994), Analysis of growth fractions of renal cell carcinoma by the monoclonal antibody Ki-67. Nippon Hinyokika Gakkai Zasshi 85, 649-654
49. Staunton MJ, Gaffney EF (1995) Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 103, 300-307
50. Stewart BW (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86, 1286-1296
51. Sträfer J, Gunthert AR, Bruderlein S, Moller P (1995) Microwave irradiation of paraffin embedded tissue sensitizes the TUNEL method for in situ detection of apoptotic cells. Histochem Cell Biol 103, 157-160
52. Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Path Res Pract 181, 125-143
53. Tomasino RM, Morello V, Tralongu V, Nagar C, Nuara R, Daniele E, Curti M, Orestano F (1994) p53 expression in human renal cell carcinoma: an immunohistochemical study and a literature outline of the cytogenetic characterization. Pathologica 86, 227-233
54. Uhlman DL, Nguyen PL, Manivel JC, Aeppli D, Resnick JM, Fraley EE, Zhang G, Niehans GA (1994) Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 86, 1470-1475
55. Vesalainen S, Lipponen P, Talja M, Syrjanen K (1994) Histological grade, perineural infiltration, tumor-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A, 1797-1803
56. Yasuda M, Umemura S, Osamura Y, Kenjo T, Tsutsumi Y (1995) Apoptotic cells in human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Hist Cytol 58, 185-190